John leads the Patient Health & Impact Global Healthcare Innovation Center at Pfizer. His team designs new models of access, value-based contracting, innovative financing, and forges new partnerships across the healthcare sector to facilitate our move to value-based healthcare.
Prior to joining Pfizer, John led the Global Enterprise Solutions team at IQVIA, providing technology-enabled real world evidence platforms and research networks to help transform biopharmaceutical industry engagement with healthcare systems worldwide. Before that, John led the Global Value & Outcomes Center of Excellence at Quintiles, overseeing innovative pricing and market access, policy analysis, and health economics and outcomes research. Prior to joining Quintiles, John served as President of Analytica International, providing health economics, outcomes research, and real world evidence services to the global biopharmaceutical industry. Before co-founding Analytica, he led the Health Economics Research team for the Center for Health Outcomes and Economics at Bristol-Myers Squibb Company.
John has over 25 years of experience working in the industry and is very active in thought leadership including representing the contract research organization industry in the National Academy of Sciences, Engineering, and Medicine's Real World Evidence Workshop and co-chairing the Alliance for Regenerative Medicine Foundation's Economic Impact Steering Committee. He has published more than 50 peer-reviewed papers and serves as an Adjunct Assistant Professor of Epidemiology at Columbia University.
John earned a Doctorate and Masters of Public Health degree in Epidemiology from the Mailman School of Public Health at Columbia University and a Bachelor of Science degree in Business Management and Applied Economics with a concentration in the Life Sciences at Cornell University.